Is Celularity Inc (CELU) Stock About to Get Hot Friday?

Overall market sentiment has been down on Celularity Inc (CELU) stock lately. CELU receives a Bearish rating from InvestorsObserver Stock Sentiment Indicator.

Celularity Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on CELU!

See Full CELU Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With CELU Stock Today?

Celularity Inc (CELU) stock is higher by 4.82% while the S&P 500 is down -0.62% as of 3:00 PM on Friday, Aug 5. CELU has gained $0.13 from the previous closing price of $2.80 on volume of 350,126 shares. Over the past year the S&P 500 is lower by -6.28% while CELU is down -66.09%. CELU lost -$3.06 per share in the over the last 12 months. To screen for more stocks like Celularity Inc click here.

More About Celularity Inc

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. Click Here to get the full Stock Report for Celularity Inc stock.